Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. HDOG HUB Message Board

$AVEO Company News Aveo loss widens on revenue d

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 72741
Posted On: 01/10/2014 4:50:53 PM
Avatar
Posted By: Stock_Tracker
$AVEO Company News

Aveo loss widens on revenue drop; shares down 8:48 a.m. April 30, 2013 - MarketWatch.com
Updates, advisories and surprises 4:01 p.m. Aug. 2, 2012 - MarketWatch
Thursday’s biggest gaining and declining stocks 12:11 p.m. Aug. 2, 2012 - MarketWatch
Aveo sinks 27% after FDA update, earnings 10:57 a.m. Aug. 2, 2012 - Val Brickates Kennedy
Aveo dives 25% on FDA update 9:57 a.m. Aug. 2, 2012 - Val Brickates Kennedy
Dividends don't lie 8:51 a.m. Jan. 9, 2012 - The Trading Deck
Aveo cancer treatment meets goal, but shares drop 2:43 p.m. Jan. 3, 2012 - MarketWatch.com
Aveo reports progress with cancer-drug candidate 6:58 a.m. Jan. 3, 2012 - MarketWatch.com
Updates, advisories and surprises 4:31 p.m. July 28, 2011 - MarketWatch
AVEO climbs on earnings, outlook 11:18 a.m. July 28, 2011 - Val Brickates Kennedy
Wednesday’s biggest gaining and declining stocks 3:46 p.m. June 15, 2011 - Kate Gibson
Regeneron energizes biotech stocks 2:37 p.m. June 15, 2011 - Val Brickates Kennedy
AVEO shares tumble 10% on stock offer pricing 9:19 a.m. June 15, 2011 - Val Brickates Kennedy
Inspire, AVEO take lead in drug-stocks trading 3:14 p.m. Feb. 17, 2011 - Val Brickates Kennedy
AVEO shares jump on Astellas pact 11:04 a.m. Feb. 17, 2011 - Val Brickates Kennedy

Biotech 2013 By The Numbers: A Blockbuster Year 9:13 a.m. Jan. 1, 2014 - TheStreet.com
AVEO Pharmaceuticals, Inc. (AVEO) Catches Eye: Stock Rises 8% - Tale of the Tape 8:44 a.m. Dec. 31, 2013 - Zacks.com
Chelsea: FDA Panel Meeting And Trading Strategies 4:34 p.m. Dec. 30, 2013 - Seeking Alpha
The Worst Biotech CEO of 2013 Is... 7:58 a.m. Dec. 17, 2013 - TheStreet.com
AVEO Falls on Tivozanib News - Analyst Blog 6:20 p.m. Dec. 16, 2013 - Zacks.com
Monday's healthcare upgrades, downgrades, and initiations 9:49 a.m. Dec. 16, 2013 - Seeking Alpha
Aveo says lead drug unlikely to succeed in colon cancer study, -15% 11:06 a.m. Dec. 13, 2013 - Seeking Alpha
AVEO Says Tivozanib Trial in Colorectal Cancer Unlikely to Meet Primary Endpoint 5:53 a.m. Dec. 13, 2013 - benzinga.com
Your Vote Counts: Who is the Worst Biotech CEO of 2013? 8:32 a.m. Dec. 12, 2013 - TheStreet.com
Tracking Seth Klarman's Baupost Group Holdings - Q3 2013 Update 12:24 a.m. Nov. 14, 2013 - Seeking Alpha
AVEO Q3 Loss Wider than Expected, Shares Down - Analyst Blog 9:30 a.m. Nov. 12, 2013 - Zacks.com
10-Q: AVEO PHARMACEUTICALS INC 6:33 a.m. Nov. 7, 2013 - Edgar Online - (EDG = 10Q, 10K)
Karyopharm Therapeutics IPO Looks Promising 7:44 a.m. Nov. 6, 2013 - Seeking Alpha
Wild Card Wonders, Shopping for 52-Week Lows 9:04 p.m. Sept. 28, 2013 - GuruFocus.com
Sleepy Sector Wakes Up - Billionaires Hold Biotechs in 52-week Low 12:52 p.m. Sept. 3, 2013 - GuruFocus.com
Looking At AVEO With Fresh Eyes 9:47 a.m. Aug. 29, 2013 - Seeking Alpha
5 Stupidest Small-Cap Stock Investments 3:29 a.m. Aug. 27, 2013 - InvestorPlace.com
9 Compelling Reasons To Buy Opexa Therapeutics Right Now 11:44 a.m. Aug. 15, 2013 - Seeking Alpha
Cutting Loose: Seth Klarman's Active Second Quarter Selling and Trimming 5:51 p.m. Aug. 14, 2013 - GuruFocus.com
Tracking Seth Klarman's Baupost Group Holdings - Q2 2013 Update 11:57 a.m. Aug. 14, 2013 - Seeking Alpha


Annual Changes to the NASDAQ Biotechnology Index 8:05 a.m. Dec. 16, 2013 - GlobeNewswire
AVEO Provides Update on Interim Analysis from Tivozanib Trial in Colorectal Cancer 6:50 a.m. Dec. 13, 2013 - BusinessWire
AVEO Reports Third Quarter 2013 Financial Results 6:32 a.m. Nov. 7, 2013 - BusinessWire
Flagship VentureLabs Launches Midori Renewables 12:18 p.m. Sept. 4, 2013 - PR Newswire
AVEO Oncology to Present at the Morgan Stanley Global Healthcare Conference 5:30 a.m. Sept. 4, 2013 - BusinessWire
The World Economic Forum Recognizes Four Flagship Ventures Portfolio Companies as Technology Pioneers for 2014 2:48 p.m. Aug. 28, 2013 - PR Newswire
AVEO Oncology to Present at the Canaccord Genuity 33rd Annual Growth Conference 5:30 a.m. Aug. 9, 2013 - BusinessWire
AVEO Reports Second Quarter 2013 Financial Results 5:30 a.m. Aug. 8, 2013 - BusinessWire
Five Star Equities Issues New Research Reports on ATHN, AVEO, EW and QSII 7:43 a.m. July 15, 2013 - ACCESSWIRE
Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Aveo Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- AVEO 9:24 a.m. July 7, 2013 - GlobeNewswire
Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Aveo Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- AVEO 12:48 p.m. June 28, 2013 - GlobeNewswire
DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders of AVEO Pharmaceuticals, Inc. of Upcoming Deadline 4:22 p.m. June 25, 2013 - BusinessWire
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in AVEO Pharmaceuticals, Inc. to Contact the Firm -- AVEO 4:00 p.m. June 25, 2013 - GlobeNewswire
Law Offices of Todd M. Garber Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. 7:41 p.m. June 24, 2013 - BusinessWire
Flagship Ventures Kicks-off its VentureLabs(TM) Entrepreneurial Fellowship Program 8:15 a.m. June 20, 2013 - PR Newswire
Glancy Binkow & Goldberg Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. 8:32 a.m. June 17, 2013 - BusinessWire
Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Aveo Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- AVEO 3:19 p.m. June 14, 2013 - GlobeNewswire
Law Offices of Todd M. Garber Announces Class Action Lawsuit Against AVEO Pharmaceuticals, Inc. 2:27 p.m. June 12, 2013 - BusinessWire
AVEO Announces Complete Response Letter Received for Tivozanib New Drug Application in Renal Cell Carcinoma 5:30 a.m. June 10, 2013 - BusinessWire
AVEO Oncology Announces Strategic Restructuring 3:30 p.m. June 4, 2013 - BusinessWire



(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us